Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
Authors:
- Yoshinari AsaokaYAYoshinari Asaoka
- Ryosuke TateishiRTRyosuke Tateishi
- Ryo NakagomiRNRyo Nakagomi
- Mayuko KondoMKMayuko Kondo
- Naoto FujiwaraNFNaoto Fujiwara
- Tatsuya MinamiTMTatsuya Minami
- Masaya SatoMSMasaya Sato
- Koji UchinoKUKoji Uchino
- Hayato NakagawaHNHayato Nakagawa
- Yuji KondoYKYuji Kondo
- Shuichiro ShiinaSSShuichiro Shiina
Open Access
- 14 November 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (11) , e111662
Abstract
Vascular invasion in patients with hepatocellular carcinoma (HCC) is representative of advanced disease with an extremely poor prognosis. The detailed course of its development has not been fully elucidated. We enrolled 1057 consecutive patients with HCC who had been treated with curative intent by radiofrequency ablation (RFA) as an initial therapy from 1999 to 2008 at our department. We analyzed the incidence rate of and predictive factors for vascular invasion. The survival rate after detection of vascular invasion was also analyzed. During a mean follow-up period of 4.5 years, 6075 nodules including primary and recurrent lesions were treated by RFA. Vascular invasion was observed in 97 patients. The rate of vascular invasion associated with site of original RFA procedure was 0.66% on a nodule basis. The incidence rates of vascular invasion on a patient basis at 1, 3, and 5 years were 1.1%, 5.9%, and 10.4%, respectively. Univariate analysis revealed that tumor size, tumor number, alpha-fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), and Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein were significant risk predictors of vascular invasion. In multivariate analysis, DCP was the most significant predictor for vascular invasion (compared with a DCP of ≤100 mAu/mL, the hazard ratio was 1.95 when DCP was 101–200 mAu/mL and 3.22 when DCP was >200 mAu/mL). The median survival time after development of vascular invasion was only 6 months. Vascular invasion occurs during the clinical course of patients initially treated with curative intent. High-risk patients may be identified using tumor markers.Keywords
This publication has 38 references indexed in Scilit:
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic FactorsAmerican Journal of Gastroenterology, 2012
- Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-γ-carboxy prothrombin production in hepatocellular carcinomaInternational Journal of Oncology, 2009
- Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis CHepatology International, 2009
- PIVKA-II Is the Best Prognostic Predictor in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation TherapyOncology, 2008
- The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des‐gamma‐carboxy prothrombinJournal of Surgical Oncology, 2007
- Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markersHepatology, 2006
- Percutaneous radiofrequency thermal ablation for hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2006
- Factors correlated with portal venous invasion by hepatocellular carcinoma: Univariate and multivariate analyses of 232 resected cases without preoperative treatmentsCancer, 1996
- Repeat hepatectomy for recurrent hepatocellular carcinomaBritish Journal of Surgery, 1996
- CT of hepatoma: effects of portal vein obstructionAmerican Journal of Roentgenology, 1981